Phase 1 Refractory Medulloblastoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

MeningiomaRecurrent Diffuse Intrinsic Pontine GliomaHigh Grade Glioma+10 more

Nationwide Children's Hospital65 enrolled4 locationsNCT05278208

Recruiting

Phase 1

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

CNS MetastasesRecurrent MedulloblastomaRefractory Medulloblastoma+1 more

Memorial Sloan Kettering Cancer Center18 enrolled7 locationsNCT07698899

Recruiting

Phase 1

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Pediatric Brain TumorPineoblastomaMedulloblastoma+7 more

Stanford University18 enrolled1 locationNCT07087002